1. Introducing the HemaSphere Controversies Series. Issue 5 (October 2019) Authors: Eichenauer, Dennis A.; Cools, Jan; Engert, Andreas Journal: HemaSphere Issue: Volume 3:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors. Issue 6 (December 2019) Authors: Govaerts, Inge; Jacobs, Kris; Vandepoel, Roel; Cools, Jan Journal: HemaSphere Issue: Volume 3:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia. Issue 6 (December 2019) Authors: Verbeke, Delphine; Gielen, Olga; Jacobs, Kris; Boeckx, Nancy; De Keersmaecker, Kim; Maertens, Johan; Uyttebroeck, Anne; Segers, Heidi; Cools, Jan Journal: HemaSphere Issue: Volume 3:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗